ABBV

SELL

AbbVie Inc.

Healthcare · Rank #310 · Analyzed Oct 18, 2026

$285.42

Current Price

$218.51

Intrinsic Value

low confidence

Upside/Downside

2/10

Score

2/5

Quality

Analysis Summary

Valuation Consensus1/2 methods agree

Quality Score2/5.0

Framework RatingSELL

Price vs Intrinsic ValueLow confidence — see rating

Fair Value Range

Low$63.47

Base (IV)$218.51

High$746.81

Entry Points

Conservative$44.43

Moderate$63.47

Aggressive$152.96

⚠️ Warnings

DCF/EPV diverge 8.3x — earnings power and cash flow disagree; fair value is low-confidence (blended conservatively)

Quality & Moat Breakdown

Return on Equity0.0% → 0/1.0

Debt LevelD/E 100 → 0/1.0

Revenue QualityGrowth 7.7%, margin Δ+2.7% +recovery → 1.0/1.0

Moat Strength3.5/5 → 0.5/1.0

Profit Margins9.8% → 0.5/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.